To understand the apparent synergy between TIM-3 blockade and CD137 activation in the ID8 tumor model, we sought to dissect the effects of single or combined mAb on tumor-infiltrating immune cells (TIIC) in peritoneal lavage. This evidence concerns the gene HAVCR2 and neoplasm.